Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guérin (BCG) vaccine
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2GEP3_178155)
This publication has 35 references indexed in Scilit:
- Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and StoragePLOS ONE, 2012
- Comparative Tuberculosis (TB) Prevention Effectiveness in Children of Bacillus Calmette-Guérin (BCG) Vaccines from Different Sources, KazakhstanPLOS ONE, 2012
- BCG-Mediated Protection against Mycobacterium ulcerans Infection in the MousePLOS Neglected Tropical Diseases, 2011
- Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer DiseaseThe Journal of Infectious Diseases, 2009
- Systemic and local interferon-gamma production following Mycobacterium ulcerans infectionClinical and Experimental Immunology, 2007
- A Booster Vaccination with Mycobacterium bovis BCG Does Not Increase the Protective Effect of the Vaccine against Experimental Mycobacterium ulcerans Infection in MiceInfection and Immunity, 2007
- Risk Factors for Buruli Ulcer, BeninEmerging Infectious Diseases, 2006
- Risk Factors for Buruli Ulcer Disease (Mycobacterium ulcerans Infection): Results from a Case-Control Study in GhanaClinical Infectious Diseases, 2005
- Protective Efficacy of a DNA Vaccine Encoding Antigen 85A from Mycobacterium bovis BCG against Buruli UlcerInfection and Immunity, 2001
- Immune Response to Infection withMycobacterium ulceransInfection and Immunity, 2001